The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

The Food and Drug Administration on Tuesday approved the first drug in a new class of antibiotics for treating urinary tract infections — the first time that’s happened in nearly 30 years.

In kids with a febrile urinary tract infection (UTI), an individualized duration of antibiotics led to an increased risk of recurrent UTI compared with a 10-day course. However, the individualized ...

Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions worldwide. However, the increasing resistance of bacteria to standard antibiotics has made ...

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The medication, gepotidacin, targets E. coli bacteria, which is responsible ...

March 26, 2025 — The FDA has approved a new medication to treat uncomplicated urinary tract infections in women and girls aged 12 or older. It is the first in a new class of oral antibiotics ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials ...

For millions of women, urinary tract infections (UTIs) are more than just a minor health nuisance – they are a recurring, disruptive burden. With rising antibiotic resistance making standard ...